Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: A randomized human trial

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 2, 2006, Pages

  Chiang, Nan ^a   Hurwitz, Shelley ^a   Ridker, Paul M ^a   Serhan, Charles N ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Thorn Building for Medical Research ^*  (United States)

Author keywords

Inflammation; Leukocyte traffic; Lipid mediators

Indexed keywords

15 EPI LIPOXIN A4; ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 2 INHIBITOR; LIPOXIN A; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; THROMBOXANE B2; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2; LIPOXIN; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; AGE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LOW DRUG DOSE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ACETYLATION; AGED; METABOLISM; MIDDLE AGED; SEXUAL DEVELOPMENT;

ACETYLATION; ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; HUMANS; LIPOXINS; MIDDLE AGED; PLACEBOS; SEX CHARACTERISTICS; THROMBOXANE B2;

EID: 33644852178     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000196729.98651.bf     Document Type: Article

References (17)

1. Flower R. What are all the things that aspirin does? BMJ. 2003;327:572-573.
2. Marcus AJ. Platelets: their role in hemostasis, thrombosis, and inflammation. In Gallin JI, Snyderman R, Fearon DT, Haynes BF, Nathan C, eds. Inflammation: Basic Principles and Clinical Correlates. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:77-95.
3. Chiang N, Arita M, Serhan CN. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot Essent Fatty Acids. 2005;73:163-177.
4. Levy BD, Serhan CN. Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin-triggered lipid mediators. Drugs Today (Barc). 2003;39:373-384.
5. Claria J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci U S A. 1995;92:9475-9479.
6. Chiang C, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN. Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci U S A. 2004;101:15178-15183.
7. Levin RI. The puzzle of aspirin and sex. New Engl J Med. 2005;352:1366-1368.
8. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293-1304.
9. Stewart KG, Zhang Y, Davidge ST. Estrogen decreases prostaglandin H synthase products from endothelial cells. J Soc Gynecol Investig. 1999;6:322-327.
10. Henriksson P, Stege R, Green K. Profound decrease of in vivo formation of thromboxane during oestrogen therapy. Eur J Clin Invest. 1996;26:1186-1188.
11. Wikstrom E, Westlund P, Nicolaou KC, Dahlen SE. Lipoxin A4-induced release of thromboxane in the guinea-pig lung: studies of its characteristics using lipoxin A4-methyl ester. J Lipid Mediators. 1992;5:205-217.
12. Wallace JL, Fiorucci S. A magic bullet for mucosal protection. . .and aspirin is the trigger! Trends Pharmacol Sci. 2003;24:323-326.
13. Fiorucci S, Wallace JL, Mencarelli A, Distrutti E, Rizzo G, Farneti S, Morelli A, Tseng JL, Suramanyam B, Guilford WJ, Parkinson JF. A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc Natl Acad Sci U S A. 2004;101:15736-15741.
14. Serhan CN, Gotlinger K, Hong S, Arita M. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 2004;73:155-172.
15. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. J Am Med Assoc. 2005;294:47-55.
16. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333:609-614.
17. Marcus AJ. Aspirin as prophylaxis against colorectal cancer. N Engl J Med. 1995;333:656-658.